Literature DB >> 2076907

Verotoxigenic (enterohaemorrhagic) Escherichia coli in infants and toddlers in Czechoslovakia.

M Bielaszewská1, L Srámková, J Janda, K Bláhová, H Ambrozová.   

Abstract

The results of the investigation indicate that verotoxigenic Escherichia coli (VTEC) belonging to enteropathogenic and other serogroups including Escherichia coli O157:H7 or H- are important enteropathogens in infants and toddlers in Czechoslovakia. As to enteropathogenic serotypes, verotoxin (VT) production was proved most frequently in strains of serogroup O26, and also O111 and O128. Diseases caused by them were as a rule manifested by febrile watery diarrhoea with mucus in the stool. In two of five infants with Escherichia coli O26 :H11 with VT1 production in titres of greater than or equal to 1:512 (blood was present) in the stool and one suffered from marked abdominal pain. In one infant haemorrhagic colitis due to Escherichia coli O157:H- was found. Haemolytic uraemic syndrome associated with VTEC of serogroups O157, O26, O18, O5 and O1 with VT1 and/or VT2 was observed in six children including five who contracted the disease during an outbreak in a small town, and the source of infection was probably contaminated water. Five children recovered and one died; the postmortem examination revealed haemorrhagic colitis and necrosis of the renal cortex. Haemorrhagic colitis caused by Escherichia coli O157 in infants and toddlers differed from the course hitherto described in older subjects by fever and the presence of mucus in the stools.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076907     DOI: 10.1007/BF01646403

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  26 in total

1.  Integrated cardiac, renal, and endocrine actions of endothelin.

Authors:  W L Miller; M M Redfield; J C Burnett
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets.

Authors:  S Tzipori; I K Wachsmuth; C Chapman; R Birden; J Brittingham; C Jackson; J Hogg
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

Review 3.  Endothelin: an important factor in acute renal failure?

Authors:  J D Firth; P J Ratcliffe; A E Raine; J G Ledingham
Journal:  Lancet       Date:  1988-11-19       Impact factor: 79.321

4.  Cytopathic effect of verotoxin on endothelial cells.

Authors:  J Kavi; I Chant; M Maris; P E Rose
Journal:  Lancet       Date:  1987-10-31       Impact factor: 79.321

5.  Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2.

Authors:  S M Scotland; G A Willshaw; H R Smith; B Rowe
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

6.  Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings.

Authors:  C A Ryan; R V Tauxe; G W Hosek; J G Wells; P A Stoesz; H W McFadden; P W Smith; G F Wright; P A Blake
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

7.  Phage-associated cytotoxin production by and enteroadhesiveness of enteropathogenic Escherichia coli isolated from infants with diarrhea in West Germany.

Authors:  H Karch; J Heesemann; R Laufs
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

8.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive.

Authors:  M M Levine; E J Bergquist; D R Nalin; D H Waterman; R B Hornick; C R Young; S Sotman
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.